BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science. 2013;341:295-298. [PMID: 23869020 DOI: 10.1126/science.1235872] [Cited by in Crossref: 339] [Cited by in F6Publishing: 294] [Article Influence: 37.7] [Reference Citation Analysis]
Number Citing Articles
1 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
2 van Kessel SP, de Jong HR, Winkel SL, van Leeuwen SS, Nelemans SA, Permentier H, Keshavarzian A, El Aidy S. Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol 2020;18:137. [PMID: 33076930 DOI: 10.1186/s12915-020-00876-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Walsh J, Griffin BT, Clarke G, Hyland NP. Drug-gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol 2018;175:4415-29. [PMID: 29782640 DOI: 10.1111/bph.14366] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
4 Hitchings R, Kelly L. Predicting and Understanding the Human Microbiome's Impact on Pharmacology. Trends Pharmacol Sci 2019;40:495-505. [PMID: 31171383 DOI: 10.1016/j.tips.2019.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
5 Ma Y, Liu L, Chen Q, Ma Y. An Inductive Logistic Matrix Factorization Model for Predicting Drug-Metabolite Association With Vicus Regularization. Front Microbiol 2021;12:650366. [PMID: 33868209 DOI: 10.3389/fmicb.2021.650366] [Reference Citation Analysis]
6 Guo YP, Chen MY, Shao L, Zhang W, Rao T, Zhou HH, Huang WH. Quantification of Panax notoginseng saponins metabolites in rat plasma with in vivo gut microbiota-mediated biotransformation by HPLC-MS/MS. Chin J Nat Med 2019;17:231-40. [PMID: 30910060 DOI: 10.1016/S1875-5364(19)30026-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Feng W, Liu J, Huang L, Tan Y, Peng C. Gut microbiota as a target to limit toxic effects of traditional Chinese medicine: Implications for therapy. Biomed Pharmacother 2021;133:111047. [PMID: 33378954 DOI: 10.1016/j.biopha.2020.111047] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hitchings R, Kelly L. Drug Metabolism as a Community Effort. Cell Metab 2019;30:235-7. [PMID: 31390549 DOI: 10.1016/j.cmet.2019.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Stephens C, Lucena MI, Andrade RJ. Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 477-96. [DOI: 10.1007/978-1-4939-7677-5_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Longman RS, Littman DR. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity. Curr Opin Rheumatol 2015;27:381-7. [PMID: 26002030 DOI: 10.1097/BOR.0000000000000190] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
11 Hammer TJ, Bowers MD. Gut microbes may facilitate insect herbivory of chemically defended plants. Oecologia 2015;179:1-14. [DOI: 10.1007/s00442-015-3327-1] [Cited by in Crossref: 107] [Cited by in F6Publishing: 82] [Article Influence: 15.3] [Reference Citation Analysis]
12 Thorasin T, Hoyles L, McCartney AL. Dynamics and diversity of the 'Atopobium cluster' in the human faecal microbiota, and phenotypic characterization of 'Atopobium cluster' isolates. Microbiology. 2015;161:565-579. [PMID: 25533445 DOI: 10.1099/mic.0.000016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
13 Lindell AE, Zimmermann-kogadeeva M, Patil KR. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat Rev Microbiol. [DOI: 10.1038/s41579-022-00681-5] [Reference Citation Analysis]
14 [DOI: 10.1101/538215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kang D, Shi B, Erfe MC, Craft N, Li H. Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci Transl Med 2015;7:293ra103. [PMID: 26109103 DOI: 10.1126/scitranslmed.aab2009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 12.0] [Reference Citation Analysis]
16 Dong H, Zhang S, Chen Z, Tao H, Li X, Qiu J, Cui W, Sima Y, Cui W, Xu S. Differences in gut microbiota between silkworms ( Bombyx mori ) reared on fresh mulberry ( Morus alba var. multicaulis) leaves or an artificial diet. RSC Adv 2018;8:26188-200. [DOI: 10.1039/c8ra04627a] [Cited by in Crossref: 12] [Article Influence: 3.0] [Reference Citation Analysis]
17 Klünemann M, Schmid M, Patil KR. Computational tools for modeling xenometabolism of the human gut microbiota. Trends Biotechnol. 2014;32:157-165. [PMID: 24529988 DOI: 10.1016/j.tibtech.2014.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
18 Patterson AD, Turnbaugh PJ. Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology. Cell Metab 2014;20:761-8. [PMID: 25156450 DOI: 10.1016/j.cmet.2014.07.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
19 Bisanz JE, Soto-Perez P, Noecker C, Aksenov AA, Lam KN, Kenney GE, Bess EN, Haiser HJ, Kyaw TS, Yu FB, Rekdal VM, Ha CWY, Devkota S, Balskus EP, Dorrestein PC, Allen-Vercoe E, Turnbaugh PJ. A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria. Cell Host Microbe 2020;27:1001-1013.e9. [PMID: 32348781 DOI: 10.1016/j.chom.2020.04.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Houghton D, Hardy T, Stewart C, Errington L, Day CP, Trenell MI, Avery L. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes. Diabetologia 2018;61:1700-11. [PMID: 29754286 DOI: 10.1007/s00125-018-4632-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
21 Sommer MO. Advancing gut microbiome research using cultivation. Curr Opin Microbiol 2015;27:127-32. [PMID: 26401902 DOI: 10.1016/j.mib.2015.08.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
22 Haiser HJ, Seim KL, Balskus EP, Turnbaugh PJ. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 2014;5:233-8. [PMID: 24637603 DOI: 10.4161/gmic.27915] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 10.6] [Reference Citation Analysis]
23 Venturelli OS, Carr AC, Fisher G, Hsu RH, Lau R, Bowen BP, Hromada S, Northen T, Arkin AP. Deciphering microbial interactions in synthetic human gut microbiome communities. Mol Syst Biol 2018;14:e8157. [PMID: 29930200 DOI: 10.15252/msb.20178157] [Cited by in Crossref: 156] [Cited by in F6Publishing: 114] [Article Influence: 39.0] [Reference Citation Analysis]
24 Vaiserman AM, Koliada AK, Marotta F. Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Res Rev 2017;35:36-45. [PMID: 28109835 DOI: 10.1016/j.arr.2017.01.001] [Cited by in Crossref: 201] [Cited by in F6Publishing: 167] [Article Influence: 40.2] [Reference Citation Analysis]
25 Wang Y, Fu Y, He Y, Kulyar MF, Iqbal M, Li K, Liu J. Longitudinal Characterization of the Gut Bacterial and Fungal Communities in Yaks. J Fungi (Basel) 2021;7:559. [PMID: 34356938 DOI: 10.3390/jof7070559] [Reference Citation Analysis]
26 Zaneveld JR, Mcminds R, Vega Thurber R. Stress and stability: applying the Anna Karenina principle to animal microbiomes. Nat Microbiol 2017;2. [DOI: 10.1038/nmicrobiol.2017.121] [Cited by in Crossref: 282] [Cited by in F6Publishing: 225] [Article Influence: 56.4] [Reference Citation Analysis]
27 Martinez KB, Leone V, Chang EB. Microbial metabolites in health and disease: Navigating the unknown in search of function. J Biol Chem. 2017;292:8553-8559. [PMID: 28389566 DOI: 10.1074/jbc.r116.752899] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 11.8] [Reference Citation Analysis]
28 Carmody RN, Gerber GK, Luevano JM Jr, Gatti DM, Somes L, Svenson KL, Turnbaugh PJ. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 2015;17:72-84. [PMID: 25532804 DOI: 10.1016/j.chom.2014.11.010] [Cited by in Crossref: 576] [Cited by in F6Publishing: 517] [Article Influence: 72.0] [Reference Citation Analysis]
29 Guo Y, Lee H, Jeong H. Gut microbiota in reductive drug metabolism. Prog Mol Biol Transl Sci 2020;171:61-93. [PMID: 32475528 DOI: 10.1016/bs.pmbts.2020.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
30 Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. Specialized metabolites from the microbiome in health and disease. Cell Metab 2014;20:719-30. [PMID: 25440054 DOI: 10.1016/j.cmet.2014.10.016] [Cited by in Crossref: 290] [Cited by in F6Publishing: 268] [Article Influence: 36.3] [Reference Citation Analysis]
31 Zhou H, Sun J, Yu B, Liu Z, Chen H, He J, Mao X, Zheng P, Yu J, Luo J, Luo Y, Yan H, Ge L, Chen D. Gut microbiota absence and transplantation affect growth and intestinal functions: An investigation in a germ-free pig model. Anim Nutr 2021;7:295-304. [PMID: 34258417 DOI: 10.1016/j.aninu.2020.11.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 2020;13:637-56. [PMID: 31984651 DOI: 10.1111/1751-7915.13524] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
33 Redinbo MR. The microbiota, chemical symbiosis, and human disease. J Mol Biol 2014;426:3877-91. [PMID: 25305474 DOI: 10.1016/j.jmb.2014.09.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
34 Devkota S. MICROBIOME. Prescription drugs obscure microbiome analyses. Science 2016;351:452-3. [PMID: 26823414 DOI: 10.1126/science.aaf1353] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
35 Koropatkin NM, Martens EC. Meds Modify Microbiome, Mediating Their Effects. Cell Metabolism 2017;26:456-7. [DOI: 10.1016/j.cmet.2017.08.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
36 Aziz RK, Rizkallah MR, Saad R, ElRakaiby MT. Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020. OMICS 2020;24:60-1. [PMID: 31916888 DOI: 10.1089/omi.2019.0205] [Reference Citation Analysis]
37 Tsunoda SM, Gonzales C, Jarmusch AK, Momper JD, Ma JD. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability. Clin Pharmacokinet 2021;60:971-84. [PMID: 33959897 DOI: 10.1007/s40262-021-01032-y] [Reference Citation Analysis]
38 Cussotto S, Clarke G, Dinan TG, Cryan JF. Psychotropics and the Microbiome: a Chamber of Secrets…. Psychopharmacology (Berl) 2019;236:1411-32. [PMID: 30806744 DOI: 10.1007/s00213-019-5185-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 15.7] [Reference Citation Analysis]
39 Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, Xavier RJ. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. Cell Host Microbe 2017; 21: 603-610. e3. [PMID: 28494241 DOI: 10.1016/j.chom.2017.04.010] [Cited by in Crossref: 150] [Cited by in F6Publishing: 132] [Article Influence: 30.0] [Reference Citation Analysis]
40 Ursell LK, Haiser HJ, Van Treuren W, Garg N, Reddivari L, Vanamala J, Dorrestein PC, Turnbaugh PJ, Knight R. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 2014;146:1470-6. [PMID: 24631493 DOI: 10.1053/j.gastro.2014.03.001] [Cited by in Crossref: 133] [Cited by in F6Publishing: 115] [Article Influence: 16.6] [Reference Citation Analysis]
41 Culligan EP, Sleator RD, Marchesi JR, Hill C. Metagenomics and novel gene discovery: promise and potential for novel therapeutics. Virulence 2014;5:399-412. [PMID: 24317337 DOI: 10.4161/viru.27208] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
42 Zhan J, Liang Y, Liu D, Ma X, Li P, Liu C, Liu X, Wang P, Zhou Z. Antibiotics may increase triazine herbicide exposure risk via disturbing gut microbiota. Microbiome 2018;6:224. [PMID: 30545405 DOI: 10.1186/s40168-018-0602-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
43 Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 2014;124:4173-81. [PMID: 25105361 DOI: 10.1172/JCI72335] [Cited by in Crossref: 155] [Cited by in F6Publishing: 84] [Article Influence: 19.4] [Reference Citation Analysis]
44 [DOI: 10.1101/870105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Wu WK, Ivanova EA, Orekhov AN. Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer. Semin Cancer Biol 2021;70:85-97. [PMID: 32610150 DOI: 10.1016/j.semcancer.2020.06.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, Zhang D, Su Z, Fang Z, Lan Z, Li J, Xiao L, Li J, Li R, Li X, Li F, Ren H, Huang Y, Peng Y, Li G, Wen B, Dong B, Chen JY, Geng QS, Zhang ZW, Yang H, Wang J, Wang J, Zhang X, Madsen L, Brix S, Ning G, Xu X, Liu X, Hou Y, Jia H, He K, Kristiansen K. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8:845. [PMID: 29018189 DOI: 10.1038/s41467-017-00900-1] [Cited by in Crossref: 424] [Cited by in F6Publishing: 400] [Article Influence: 84.8] [Reference Citation Analysis]
47 Katsila T, Balasopoulou A, Tsagaraki I, Patrinos GP. Pharmacomicrobiomics informs clinical pharmacogenomics. Pharmacogenomics 2019;20:731-9. [PMID: 31368841 DOI: 10.2217/pgs-2019-0027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Li H, He J, Jia W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 2016;12:31-40. [PMID: 26569070 DOI: 10.1517/17425255.2016.1121234] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 14.0] [Reference Citation Analysis]
49 Miyoshi J, Nobutani K, Musch MW, Ringus DL, Hubert NA, Yamamoto M, Kase Y, Nishiyama M, Chang EB. Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100). Evid Based Complement Alternat Med 2018;2018:7415975. [PMID: 29681983 DOI: 10.1155/2018/7415975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
50 Sun Y, Baptista LC, Roberts LM, Jumbo-Lucioni P, McMahon LL, Buford TW, Carter CS. The Gut Microbiome as a Therapeutic Target for Cognitive Impairment. J Gerontol A Biol Sci Med Sci 2020;75:1242-50. [PMID: 31811292 DOI: 10.1093/gerona/glz281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
51 Sutherland VL, McQueen CA, Mendrick D, Gulezian D, Cerniglia C, Foley S, Forry S, Khare S, Liang X, Manautou JE, Tweedie D, Young H, Alekseyenko AV, Burns F, Dietert R, Wilson A, Chen C. The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps. Toxicol Sci 2020;176:1-10. [PMID: 32658296 DOI: 10.1093/toxsci/kfaa060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
52 Banerjee K, Chen J, Zhan X. Adaptive and powerful microbiome multivariate association analysis via feature selection. NAR Genom Bioinform 2022;4:lqab120. [PMID: 35047812 DOI: 10.1093/nargab/lqab120] [Reference Citation Analysis]
53 Reddel S, Del Chierico F, Quagliariello A, Giancristoforo S, Vernocchi P, Russo A, Fiocchi A, Rossi P, Putignani L, El Hachem M. Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture. Sci Rep 2019;9:4996. [PMID: 30899033 DOI: 10.1038/s41598-019-41149-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
54 Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol. 2016;12:446-455. [PMID: 27256713 DOI: 10.1038/nrrheum.2016.68] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 11.2] [Reference Citation Analysis]
55 Espenschied ST, Cronan MR, Matty MA, Mueller O, Redinbo MR, Tobin DM, Rawls JF. Epithelial delamination is protective during pharmaceutical-induced enteropathy. Proc Natl Acad Sci U S A 2019;116:16961-70. [PMID: 31391308 DOI: 10.1073/pnas.1902596116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
56 Garud NR, Pollard KS. Population Genetics in the Human Microbiome. Trends Genet 2020;36:53-67. [PMID: 31780057 DOI: 10.1016/j.tig.2019.10.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
57 Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, Ponce DM, Barker JN, Giralt S, van den Brink M, Pamer EG. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124:1174-1182. [PMID: 24939656 DOI: 10.1182/blood-2014-02-554725] [Cited by in Crossref: 457] [Cited by in F6Publishing: 436] [Article Influence: 57.1] [Reference Citation Analysis]
58 Zhu B, Xu Y, Zhao P, Yiu S, Yu H, Shi J. NNAN: Nearest Neighbor Attention Network to Predict Drug–Microbe Associations. Front Microbiol 2022;13:846915. [DOI: 10.3389/fmicb.2022.846915] [Reference Citation Analysis]
59 Priputnevich T, Lyubasovskaya L, Muravieva V, Kondrakhin A, Ignateva A, Gordeev A, Shmakov R, Sukhikh G, Yarotskaya E. Postpartum endometritis and obstetrical sepsis associated with Eggerthella lenta. Case report and review of the literature. J Matern Fetal Neonatal Med 2021;34:313-7. [PMID: 30975002 DOI: 10.1080/14767058.2019.1602602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
60 Koppel N, Bisanz JE, Pandelia ME, Turnbaugh PJ, Balskus EP. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. Elife 2018;7:e33953. [PMID: 29761785 DOI: 10.7554/eLife.33953] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 12.5] [Reference Citation Analysis]
61 Bradley PH, Pollard KS. Proteobacteria explain significant functional variability in the human gut microbiome. Microbiome 2017;5:36. [PMID: 28330508 DOI: 10.1186/s40168-017-0244-z] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 15.0] [Reference Citation Analysis]
62 Segata N. On the Road to Strain-Resolved Comparative Metagenomics. mSystems 2018;3:e00190-17. [PMID: 29556534 DOI: 10.1128/mSystems.00190-17] [Cited by in Crossref: 62] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
63 Silva M, Brunner V, Tschurtschenthaler M. Microbiota and Colorectal Cancer: From Gut to Bedside. Front Pharmacol 2021;12:760280. [PMID: 34658896 DOI: 10.3389/fphar.2021.760280] [Reference Citation Analysis]
64 Colotti G, Rinaldi T. The central role of gut microbiota in drug metabolism and personalized medicine. Future Med Chem 2020;12:1197-200. [PMID: 32466672 DOI: 10.4155/fmc-2020-0023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
65 Topol EJ. Individualized medicine from prewomb to tomb. Cell 2014;157:241-53. [PMID: 24679539 DOI: 10.1016/j.cell.2014.02.012] [Cited by in Crossref: 175] [Cited by in F6Publishing: 138] [Article Influence: 21.9] [Reference Citation Analysis]
66 Becker HEF, Penders J, Jonkers DMAE. Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations. Gastroenterology 2021:S0016-5085(21)03488-0. [PMID: 34508777 DOI: 10.1053/j.gastro.2021.07.050] [Reference Citation Analysis]
67 Poyet M, Groussin M, Gibbons SM, Avila-Pacheco J, Jiang X, Kearney SM, Perrotta AR, Berdy B, Zhao S, Lieberman TD, Swanson PK, Smith M, Roesemann S, Alexander JE, Rich SA, Livny J, Vlamakis H, Clish C, Bullock K, Deik A, Scott J, Pierce KA, Xavier RJ, Alm EJ. A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research. Nat Med 2019;25:1442-52. [PMID: 31477907 DOI: 10.1038/s41591-019-0559-3] [Cited by in Crossref: 106] [Cited by in F6Publishing: 77] [Article Influence: 35.3] [Reference Citation Analysis]
68 Sun C, Chen L, Shen Z. Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice. Saudi Pharm J 2019;27:1146-56. [PMID: 31885474 DOI: 10.1016/j.jsps.2019.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
69 Wlodarska M, Kostic AD, Xavier RJ. An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe. 2015;17:577-591. [PMID: 25974300 DOI: 10.1016/j.chom.2015.04.008] [Cited by in Crossref: 155] [Cited by in F6Publishing: 137] [Article Influence: 25.8] [Reference Citation Analysis]
70 Zhang J, Empl MT, Schneider M, Schröder B, Stadnicka-Michalak J, Breves G, Steinberg P, Sturla SJ. Gut microbial transformation of the dietary mutagen MeIQx may reduce exposure levels without altering intestinal transport. Toxicol In Vitro 2019;59:238-45. [PMID: 30954653 DOI: 10.1016/j.tiv.2019.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Turner RM, Pirmohamed M. Cardiovascular Pharmacogenomics: Expectations and Practical Benefits. Clin Pharmacol Ther 2013;95:281-93. [DOI: 10.1038/clpt.2013.234] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
72 Shen H, Tong X, Yang J, Yu L, Zhou H, Wang Y, He Y, Wan H, Li C. Biotransformation of natural hydroxycinnamic acids by gut microbiota from normal and cerebral ischemia-reperfusion injured rats: a comparative study. Food Funct 2020;11:5389-95. [DOI: 10.1039/d0fo00775g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Schönborn JW, Stewart FA, Enriquez KM, Akhtar I, Droste A, Waschina S, Beller M. Modeling Drosophila gut microbe interactions reveals metabolic interconnectivity. iScience 2021;24:103216. [PMID: 34712918 DOI: 10.1016/j.isci.2021.103216] [Reference Citation Analysis]
74 Maseda D, Ricciotti E. NSAID-Gut Microbiota Interactions. Front Pharmacol. 2020;11:1153. [PMID: 32848762 DOI: 10.3389/fphar.2020.01153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
75 Lam KN, Alexander M, Turnbaugh PJ. Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes. Cell Host Microbe 2019;26:22-34. [PMID: 31295421 DOI: 10.1016/j.chom.2019.06.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 14.0] [Reference Citation Analysis]
76 Zhang X, Cheng K, Ning Z, Mayne J, Walker K, Chi H, Farnsworth CL, Lee K, Figeys D. Exploring the Microbiome-Wide Lysine Acetylation, Succinylation, and Propionylation in Human Gut Microbiota. Anal Chem 2021;93:6594-8. [PMID: 33885279 DOI: 10.1021/acs.analchem.1c00962] [Reference Citation Analysis]
77 García-Bayona L, Coyne MJ, Hantman N, Montero-Llopis P, Von SS, Ito T, Malamy MH, Basler M, Barquera B, Comstock LE. Nanaerobic growth enables direct visualization of dynamic cellular processes in human gut symbionts. Proc Natl Acad Sci U S A 2020;117:24484-93. [PMID: 32938803 DOI: 10.1073/pnas.2009556117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Guo Y, Crnkovic CM, Won KJ, Yang X, Lee JR, Orjala J, Lee H, Jeong H. Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites. Drug Metab Dispos. 2019;47:194-202. [PMID: 30598508 DOI: 10.1124/dmd.118.084772] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
79 Steiner HE, Gee K, Giles J, Knight H, Hurwitz BL, Karnes JH. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application. Pharmacotherapy 2021. [PMID: 34820870 DOI: 10.1002/phar.2650] [Reference Citation Analysis]
80 Liou CS, Sirk SJ, Diaz CAC, Klein AP, Fischer CR, Higginbottom SK, Erez A, Donia MS, Sonnenburg JL, Sattely ES. A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont. Cell 2020;180:717-728.e19. [PMID: 32084341 DOI: 10.1016/j.cell.2020.01.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
81 Rocha BS, Laranjinha J. Nitrate from diet might fuel gut microbiota metabolism: Minding the gap between redox signaling and inter-kingdom communication. Free Radic Biol Med 2020;149:37-43. [PMID: 32045656 DOI: 10.1016/j.freeradbiomed.2020.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
82 Takahashi MK, Tan X, Dy AJ, Braff D, Akana RT, Furuta Y, Donghia N, Ananthakrishnan A, Collins JJ. A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers. Nat Commun 2018;9:3347. [PMID: 30131493 DOI: 10.1038/s41467-018-05864-4] [Cited by in Crossref: 110] [Cited by in F6Publishing: 85] [Article Influence: 27.5] [Reference Citation Analysis]
83 Sharma A, Im SH. Special issue on the human microbiome: from symbiosis to therapy. Exp Mol Med 2020;52:1361-3. [PMID: 32908210 DOI: 10.1038/s12276-020-00488-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Chen H, Nwe PK, Yang Y, Rosen CE, Bielecka AA, Kuchroo M, Cline GW, Kruse AC, Ring AM, Crawford JM, Palm NW. A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology. Cell 2019;177:1217-1231.e18. [PMID: 31006530 DOI: 10.1016/j.cell.2019.03.036] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 31.0] [Reference Citation Analysis]
85 Balasopoulou A, Patrinos GP, Katsila T. Pharmacometabolomics Informs Viromics toward Precision Medicine. Front Pharmacol 2016;7:411. [PMID: 27833560 DOI: 10.3389/fphar.2016.00411] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
86 Jia B, Han X, Kim KH, Jeon CO. Discovery and mining of enzymes from the human gut microbiome. Trends Biotechnol 2021:S0167-7799(21)00138-4. [PMID: 34304905 DOI: 10.1016/j.tibtech.2021.06.008] [Reference Citation Analysis]
87 Gaufin T, Tobin NH, Aldrovandi GM. The importance of the microbiome in pediatrics and pediatric infectious diseases. Curr Opin Pediatr 2018;30:117-24. [PMID: 29206649 DOI: 10.1097/MOP.0000000000000576] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
88 Currò D. The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues. Expert Rev Clin Pharmacol 2018;11:171-83. [PMID: 29210311 DOI: 10.1080/17512433.2018.1414598] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
89 Creekmore BC, Gray JH, Walton WG, Biernat KA, Little MS, Xu Y, Liu J, Gharaibeh RZ, Redinbo MR. Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure. mSystems 2019;4:e00452-19. [PMID: 31455640 DOI: 10.1128/mSystems.00452-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
90 Costea PI, Hildebrand F, Arumugam M, Bäckhed F, Blaser MJ, Bushman FD, de Vos WM, Ehrlich SD, Fraser CM, Hattori M, Huttenhower C, Jeffery IB, Knights D, Lewis JD, Ley RE, Ochman H, O'Toole PW, Quince C, Relman DA, Shanahan F, Sunagawa S, Wang J, Weinstock GM, Wu GD, Zeller G, Zhao L, Raes J, Knight R, Bork P. Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 2018;3:8-16. [PMID: 29255284 DOI: 10.1038/s41564-017-0072-8] [Cited by in Crossref: 320] [Cited by in F6Publishing: 277] [Article Influence: 64.0] [Reference Citation Analysis]
91 Scott TA, Quintaneiro LM, Norvaisas P, Lui PP, Wilson MP, Leung KY, Herrera-Dominguez L, Sudiwala S, Pessia A, Clayton PT. Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans. Cell. 2017;169:442-456.e18. [PMID: 28431245 DOI: 10.1016/j.cell.2017.03.040] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 21.8] [Reference Citation Analysis]
92 García CJ, Beltrán D, Tomás-Barberán FA. Human Gut Microbiota Metabolism of Dietary Sesquiterpene Lactones: Untargeted Metabolomics Study of Lactucopicrin and Lactucin Conversion In Vitro and In Vivo. Mol Nutr Food Res 2020;64:e2000619. [PMID: 32970341 DOI: 10.1002/mnfr.202000619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
93 Cui JJ, Wang LY, Tan ZR, Zhou HH, Zhan X, Yin JY. MASS SPECTROMETRY-BASED PERSONALIZED DRUG THERAPY. Mass Spectrom Rev 2020;39:523-52. [PMID: 31904155 DOI: 10.1002/mas.21620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
94 Carbonero F. Human epigenetics and microbiome: the potential for a revolution in both research areas by integrative studies. Future Sci OA 2017;3:FSO207. [PMID: 28884004 DOI: 10.4155/fsoa-2017-0046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Young RB, Marcelino VR, Chonwerawong M, Gulliver EL, Forster SC. Key Technologies for Progressing Discovery of Microbiome-Based Medicines. Front Microbiol 2021;12:685935. [PMID: 34239510 DOI: 10.3389/fmicb.2021.685935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Koh A, Mannerås-Holm L, Yunn NO, Nilsson PM, Ryu SH, Molinaro A, Perkins R, Smith JG, Bäckhed F. Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation. Cell Metab 2020;32:643-653.e4. [PMID: 32783890 DOI: 10.1016/j.cmet.2020.07.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
97 Collins SL, Patterson AD. The gut microbiome: an orchestrator of xenobiotic metabolism. Acta Pharm Sin B 2020;10:19-32. [PMID: 31998605 DOI: 10.1016/j.apsb.2019.12.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
98 Peng R, Ma SR, Fu J, Han P, Pan LB, Zhang ZW, Yu H, Wang Y. Transforming of Triptolide into Characteristic Metabolites by the Gut Microbiota. Molecules 2020;25:E606. [PMID: 32019202 DOI: 10.3390/molecules25030606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Long Y, Wu M, Liu Y, Kwoh CK, Luo J, Li X. Ensembling graph attention networks for human microbe-drug association prediction. Bioinformatics 2020;36:i779-86. [PMID: 33381844 DOI: 10.1093/bioinformatics/btaa891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
100 Couvillion SP, Agrawal N, Colby SM, Brandvold KR, Metz TO. Who Is Metabolizing What? Discovering Novel Biomolecules in the Microbiome and the Organisms Who Make Them. Front Cell Infect Microbiol 2020;10:388. [PMID: 32850487 DOI: 10.3389/fcimb.2020.00388] [Reference Citation Analysis]
101 Li SX, Armstrong A, Neff CP, Shaffer M, Lozupone CA, Palmer BE. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy. Clin Pharmacol Ther 2016;99:600-11. [PMID: 26940481 DOI: 10.1002/cpt.363] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
102 Zhang X, Han Y, Huang W, Jin M, Gao Z. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B 2021;11:1789-812. [PMID: 34386321 DOI: 10.1016/j.apsb.2020.09.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Wilkinson JE, Franzosa EA, Everett C, Li C, Hu FB, Wirth DF, Song M, Chan AT, Rimm E, Garrett WS, Huttenhower C; HCMPH researchers and trainees., HCMPH investigators. A framework for microbiome science in public health. Nat Med 2021;27:766-74. [PMID: 33820996 DOI: 10.1038/s41591-021-01258-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
104 Imchen M, Moopantakath J, Kumavath R, Barh D, Tiwari S, Ghosh P, Azevedo V. Current Trends in Experimental and Computational Approaches to Combat Antimicrobial Resistance. Front Genet 2020;11:563975. [PMID: 33240317 DOI: 10.3389/fgene.2020.563975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Billat PA, Roger E, Faure S, Lagarce F. Models for drug absorption from the small intestine: where are we and where are we going? Drug Discov Today 2017;22:761-75. [PMID: 28115264 DOI: 10.1016/j.drudis.2017.01.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
106 Zhang X, Li L, Butcher J, Stintzi A, Figeys D. Advancing functional and translational microbiome research using meta-omics approaches. Microbiome 2019;7:154. [PMID: 31810497 DOI: 10.1186/s40168-019-0767-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 18.7] [Reference Citation Analysis]
107 Bisanz JE, Spanogiannopoulos P, Pieper LM, Bustion AE, Turnbaugh PJ. How to Determine the Role of the Microbiome in Drug Disposition. Drug Metab Dispos 2018;46:1588-95. [PMID: 30111623 DOI: 10.1124/dmd.118.083402] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
108 Noecker C, McNally CP, Eng A, Borenstein E. High-resolution characterization of the human microbiome. Transl Res 2017;179:7-23. [PMID: 27513210 DOI: 10.1016/j.trsl.2016.07.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
109 Kumar K, Jaiswal SK, Dhoke GV, Srivastava GN, Sharma AK, Sharma VK. Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme. J Cell Biochem 2018;119:5287-96. [DOI: 10.1002/jcb.26638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
110 Nardos R, Leung ET, Dahl EM, Davin S, Asquith M, Gregory WT, Karstens L. Network-Based Differences in the Vaginal and Bladder Microbial Communities Between Women With and Without Urgency Urinary Incontinence. Front Cell Infect Microbiol 2022;12:759156. [DOI: 10.3389/fcimb.2022.759156] [Reference Citation Analysis]
111 Bastiaanssen TFS, Cussotto S, Claesson MJ, Clarke G, Dinan TG, Cryan JF. Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder. Harv Rev Psychiatry 2020;28:26-39. [PMID: 31913980 DOI: 10.1097/HRP.0000000000000243] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 38.0] [Reference Citation Analysis]
112 Alexander M, Ang QY, Nayak RR, Bustion AE, Sandy M, Zhang B, Upadhyay V, Pollard KS, Lynch SV, Turnbaugh PJ. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe 2021:S1931-3128(21)00507-2. [PMID: 34822777 DOI: 10.1016/j.chom.2021.11.001] [Reference Citation Analysis]
113 Lewis K, Strandwitz P. Microbes make metabolic mischief by targeting drugs. Nature 2019;570:453-4. [PMID: 31235939 DOI: 10.1038/d41586-019-01851-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Yan Y, Nguyen LH, Franzosa EA, Huttenhower C. Strain-level epidemiology of microbial communities and the human microbiome. Genome Med 2020;12:71. [PMID: 32791981 DOI: 10.1186/s13073-020-00765-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
115 Li X, Liu L, Cao Z, Li W, Li H, Lu C, Yang X, Liu Y. Gut microbiota as an "invisible organ" that modulates the function of drugs. Biomed Pharmacother 2020;121:109653. [PMID: 31810138 DOI: 10.1016/j.biopha.2019.109653] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
116 Zhang J, Zhang J, Wang R. Gut microbiota modulates drug pharmacokinetics. Drug Metab Rev 2018;50:357-68. [PMID: 30227749 DOI: 10.1080/03602532.2018.1497647] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
117 Feng W, Liu J, Ao H, Yue S, Peng C. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs. Theranostics 2020;10:11278-301. [PMID: 33042283 DOI: 10.7150/thno.47289] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
118 Abdelsalam NA, Ramadan AT, ElRakaiby MT, Aziz RK. Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics. Front Pharmacol 2020;11:390. [PMID: 32372951 DOI: 10.3389/fphar.2020.00390] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
119 Aziz RK, Hegazy SM, Yasser R, Rizkallah MR, ElRakaiby MT. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions. Expert Opin Drug Metab Toxicol 2018;14:1043-55. [PMID: 30269615 DOI: 10.1080/17425255.2018.1530216] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
120 Wang L, Zhou J, Gober HJ, Leung WT, Huang Z, Pan X, Li C, Zhang N, Wang L. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomed Pharmacother. 2021;133:110958. [PMID: 33171400 DOI: 10.1016/j.biopha.2020.110958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
121 Shaffer M, Borton MA, McGivern BB, Zayed AA, La Rosa SL, Solden LM, Liu P, Narrowe AB, Rodríguez-Ramos J, Bolduc B, Gazitúa MC, Daly RA, Smith GJ, Vik DR, Pope PB, Sullivan MB, Roux S, Wrighton KC. DRAM for distilling microbial metabolism to automate the curation of microbiome function. Nucleic Acids Res 2020;48:8883-900. [PMID: 32766782 DOI: 10.1093/nar/gkaa621] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 18.0] [Reference Citation Analysis]
122 Deutschman CS, Hellman J, Ferrer Roca R, De Backer D, Coopersmith CM; Research Committee of the Surviving Sepsis Campaign. The Surviving Sepsis Campaign: Basic/Translational Science Research Priorities. Crit Care Med 2020;48:1217-32. [PMID: 32697495 DOI: 10.1097/CCM.0000000000004408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
123 Bess EN, Bisanz JE, Yarza F, Bustion A, Rich BE, Li X, Kitamura S, Waligurski E, Ang QY, Alba DL, Spanogiannopoulos P, Nayfach S, Koliwad SK, Wolan DW, Franke AA, Turnbaugh PJ. Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria. Nat Microbiol 2020;5:56-66. [PMID: 31686027 DOI: 10.1038/s41564-019-0596-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
124 Ahmed T, Auble D, Berkley JA, Black R, Ahern PP, Hossain M, Hsieh A, Ireen S, Arabi M, Gordon JI. An evolving perspective about the origins of childhood undernutrition and nutritional interventions that includes the gut microbiome. Ann N Y Acad Sci 2014;1332:22-38. [PMID: 25118072 DOI: 10.1111/nyas.12487] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
125 Valdes C, Stebliankin V, Narasimhan G. Large scale microbiome profiling in the cloud. Bioinformatics 2019;35:i13-22. [PMID: 31510682 DOI: 10.1093/bioinformatics/btz356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
126 Sheth RU, Cabral V, Chen SP, Wang HH. Manipulating Bacterial Communities by in situ Microbiome Engineering. Trends Genet. 2016;32:189-200. [PMID: 26916078 DOI: 10.1016/j.tig.2016.01.005] [Cited by in Crossref: 127] [Cited by in F6Publishing: 92] [Article Influence: 21.2] [Reference Citation Analysis]
127 Mimee M, Citorik RJ, Lu TK. Microbiome therapeutics - Advances and challenges. Adv Drug Deliv Rev 2016;105:44-54. [PMID: 27158095 DOI: 10.1016/j.addr.2016.04.032] [Cited by in Crossref: 118] [Cited by in F6Publishing: 85] [Article Influence: 19.7] [Reference Citation Analysis]
128 Morgan XC, Huttenhower C. Meta’omic analytic techniques for studying the intestinal microbiome. Gastroenterology. 2014;146:1437-1448.e1. [PMID: 24486053 DOI: 10.1053/j.gastro.2014.01.049] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 13.4] [Reference Citation Analysis]
129 Douglas AE. Symbiosis as a general principle in eukaryotic evolution. Cold Spring Harb Perspect Biol 2014;6:a016113. [PMID: 24492707 DOI: 10.1101/cshperspect.a016113] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 9.6] [Reference Citation Analysis]
130 Bakshi HA, Quinn GA, Aljabali AAA, Hakkim FL, Farzand R, Nasef MM, Abuglela N, Ansari P, Mishra V, Serrano-Aroca Á, Tambuwala MM. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals (Basel) 2021;14:1211. [PMID: 34959610 DOI: 10.3390/ph14121211] [Reference Citation Analysis]
131 Bersch KL, DeMeester KE, Zagani R, Chen S, Wodzanowski KA, Liu S, Mashayekh S, Reinecker HC, Grimes CL. Bacterial Peptidoglycan Fragments Differentially Regulate Innate Immune Signaling. ACS Cent Sci 2021;7:688-96. [PMID: 34056099 DOI: 10.1021/acscentsci.1c00200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Franzosa EA, Hsu T, Sirota-Madi A, Shafquat A, Abu-Ali G, Morgan XC, Huttenhower C. Sequencing and beyond: integrating molecular 'omics' for microbial community profiling. Nat Rev Microbiol 2015;13:360-72. [PMID: 25915636 DOI: 10.1038/nrmicro3451] [Cited by in Crossref: 344] [Cited by in F6Publishing: 292] [Article Influence: 49.1] [Reference Citation Analysis]
133 Velmurugan G, Ramprasath T, Swaminathan K, Mithieux G, Rajendhran J, Dhivakar M, Parthasarathy A, Babu DD, Thumburaj LJ, Freddy AJ, Dinakaran V, Puhari SS, Rekha B, Christy YJ, Anusha S, Divya G, Suganya K, Meganathan B, Kalyanaraman N, Vasudevan V, Kamaraj R, Karthik M, Jeyakumar B, Abhishek A, Paul E, Pushpanathan M, Rajmohan RK, Velayutham K, Lyon AR, Ramasamy S. Gut microbial degradation of organophosphate insecticides-induces glucose intolerance via gluconeogenesis. Genome Biol 2017;18:8. [PMID: 28115022 DOI: 10.1186/s13059-016-1134-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 11.2] [Reference Citation Analysis]
134 Wexler AG, Bao Y, Whitney JC, Bobay LM, Xavier JB, Schofield WB, Barry NA, Russell AB, Tran BQ, Goo YA, Goodlett DR, Ochman H, Mougous JD, Goodman AL. Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc Natl Acad Sci U S A 2016;113:3639-44. [PMID: 26957597 DOI: 10.1073/pnas.1525637113] [Cited by in Crossref: 128] [Cited by in F6Publishing: 116] [Article Influence: 21.3] [Reference Citation Analysis]
135 Weinstein SB, Malanga KN, Agwanda B, Maldonado JE, Dearing MD. The secret social lives of African crested rats, Lophiomys imhausi. J Mammal 2020;101:1680-91. [PMID: 33510587 DOI: 10.1093/jmammal/gyaa127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Ruff WE, Kriegel MA. Autoimmune host-microbiota interactions at barrier sites and beyond. Trends Mol Med 2015;21:233-44. [PMID: 25771098 DOI: 10.1016/j.molmed.2015.02.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
137 Flowers SA, Bhat S, Lee JC. Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy 2020;40:704-12. [DOI: 10.1002/phar.2428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity. 2014;40:824-832. [PMID: 24950202 DOI: 10.1016/j.immuni.2014.05.015] [Cited by in Crossref: 175] [Cited by in F6Publishing: 142] [Article Influence: 21.9] [Reference Citation Analysis]
139 Heinken A, Thiele I. Systems biology of host-microbe metabolomics. Wiley Interdiscip Rev Syst Biol Med 2015;7:195-219. [PMID: 25929487 DOI: 10.1002/wsbm.1301] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
140 Maini Rekdal V, Nol Bernadino P, Luescher MU, Kiamehr S, Le C, Bisanz JE, Turnbaugh PJ, Bess EN, Balskus EP. A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols. Elife 2020;9:e50845. [PMID: 32067637 DOI: 10.7554/eLife.50845] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
141 Dietert RR. Microbiome First Medicine in Health and Safety. Biomedicines 2021;9:1099. [PMID: 34572284 DOI: 10.3390/biomedicines9091099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Watson E, MacNeil LT, Ritter AD, Yilmaz LS, Rosebrock AP, Caudy AA, Walhout AJ. Interspecies systems biology uncovers metabolites affecting C. elegans gene expression and life history traits. Cell 2014;156:759-70. [PMID: 24529378 DOI: 10.1016/j.cell.2014.01.047] [Cited by in Crossref: 113] [Cited by in F6Publishing: 82] [Article Influence: 14.1] [Reference Citation Analysis]
143 Sung J, Hale V, Merkel AC, Kim PJ, Chia N. Metabolic modeling with Big Data and the gut microbiome. Appl Transl Genom 2016;10:10-5. [PMID: 27668170 DOI: 10.1016/j.atg.2016.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
144 Buttimer C, Bottacini F, Shkoporov AN, Draper LA, Ross P, Hill C. Selective Isolation of Eggerthella lenta from Human Faeces and Characterisation of the Species Prophage Diversity. Microorganisms 2022;10:195. [DOI: 10.3390/microorganisms10010195] [Reference Citation Analysis]
145 Kumar K, Dhoke GV, Sharma AK, Jaiswal SK, Sharma VK. Mechanistic elucidation of amphetamine metabolism by tyramine oxidase from human gut microbiota using molecular dynamics simulations. J Cell Biochem 2019. [PMID: 30701587 DOI: 10.1002/jcb.28396] [Reference Citation Analysis]
146 Quinn RA, Nothias L, Vining O, Meehan M, Esquenazi E, Dorrestein PC. Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy. Trends in Pharmacological Sciences 2017;38:143-54. [DOI: 10.1016/j.tips.2016.10.011] [Cited by in Crossref: 141] [Cited by in F6Publishing: 120] [Article Influence: 28.2] [Reference Citation Analysis]
147 Luo Y, Zhou T. Connecting the dots: Targeting the microbiome in drug toxicity. Med Res Rev 2021. [PMID: 33856076 DOI: 10.1002/med.21805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Glowacki RWP, Martens EC. In sickness and health: Effects of gut microbial metabolites on human physiology. PLoS Pathog 2020;16:e1008370. [PMID: 32271839 DOI: 10.1371/journal.ppat.1008370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
149 Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 2019;364:eaau6323. [PMID: 31196984 DOI: 10.1126/science.aau6323] [Cited by in Crossref: 159] [Cited by in F6Publishing: 133] [Article Influence: 53.0] [Reference Citation Analysis]
150 Whidbey C, Wright AT. Activity-Based Protein Profiling-Enabling Multimodal Functional Studies of Microbial Communities. Curr Top Microbiol Immunol 2019;420:1-21. [PMID: 30406866 DOI: 10.1007/82_2018_128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
151 Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA. Bidirectional interactions between indomethacin and the murine intestinal microbiota. Elife 2015;4:e08973. [PMID: 26701907 DOI: 10.7554/eLife.08973] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
152 Wang Z, Koonen D, Hofker M, Fu J. Gut microbiome and lipid metabolism: from associations to mechanisms. Current Opinion in Lipidology 2016;27:216-24. [DOI: 10.1097/mol.0000000000000308] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
153 Mueller A, Brockmueller A, Fahimi N, Ghotbi T, Hashemi S, Sadri S, Khorshidi N, Kunnumakkara AB, Shakibaei M. Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment. Biomedicines 2022;10:832. [DOI: 10.3390/biomedicines10040832] [Reference Citation Analysis]
154 Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M, Ceulemans J, Corsetti M, Griffin BT, Grimm M, Keszthelyi D, Koziolek M, Madla CM, Matthys C, McCoubrey LE, Mitra A, Reppas C, Stappaerts J, Steenackers N, Trevaskis NL, Vanuytsel T, Vertzoni M, Weitschies W, Wilson C, Augustijns P. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. Eur J Pharm Sci 2021;162:105812. [PMID: 33753215 DOI: 10.1016/j.ejps.2021.105812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
155 Brüssow H. Parkinson disease, levodopa and the gut microbiota-when microbiology meets pharmacology. Environ Microbiol 2020;22:808-12. [PMID: 31950559 DOI: 10.1111/1462-2920.14919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
156 Chetal K, Janga SC. OperomeDB: A Database of Condition-Specific Transcription Units in Prokaryotic Genomes. Biomed Res Int 2015;2015:318217. [PMID: 26543854 DOI: 10.1155/2015/318217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
157 Lee JR, Muthukumar T, Dadhania D, Taur Y, Jenq RR, Toussaint NC, Ling L, Pamer E, Suthanthiran M. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015;10:e0122399. [PMID: 25815766 DOI: 10.1371/journal.pone.0122399] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 9.7] [Reference Citation Analysis]
158 Lu K, Mahbub R, Fox JG. Xenobiotics: Interaction with the Intestinal Microflora. ILAR J 2015;56:218-27. [PMID: 26323631 DOI: 10.1093/ilar/ilv018] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
159 Quinn RA, Hagiwara KA, Liu K, Goudarzi M, Pathmasiri W, Sumner LW, Metz TO. Bridging the Gap between Analytical and Microbial Sciences in Microbiome Research. mSystems 2021;6:e0058521. [PMID: 34519522 DOI: 10.1128/mSystems.00585-21] [Reference Citation Analysis]
160 Wu H, Tremaroli V, Bäckhed F. Linking Microbiota to Human Diseases: A Systems Biology Perspective. Trends Endocrinol Metab 2015;26:758-70. [PMID: 26555600 DOI: 10.1016/j.tem.2015.09.011] [Cited by in Crossref: 95] [Cited by in F6Publishing: 76] [Article Influence: 13.6] [Reference Citation Analysis]
161 Cornide-Petronio ME, Álvarez-Mercado AI, Jiménez-Castro MB, Peralta C. Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery. Nutrients 2020;12:E284. [PMID: 31973190 DOI: 10.3390/nu12020284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
162 Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Transl Res 2021;233:144-61. [PMID: 33515779 DOI: 10.1016/j.trsl.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
163 Wilson ID, Nicholson JK. The Modulation of Drug Efficacy and Toxicity by the Gut Microbiome. In: Kochhar S, Martin F, editors. Metabonomics and Gut Microbiota in Nutrition and Disease. London: Springer; 2015. pp. 323-41. [DOI: 10.1007/978-1-4471-6539-2_15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
164 Ryan PM, Stanton C, Caplice NM. Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions. Diabetol Metab Syndr 2017;9:102. [PMID: 29299069 DOI: 10.1186/s13098-017-0299-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
165 Tesei D, Jewczynko A, Lynch A, Urbaniak C. Understanding the Complexities and Changes of the Astronaut Microbiome for Successful Long-Duration Space Missions. Life 2022;12:495. [DOI: 10.3390/life12040495] [Reference Citation Analysis]
166 Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res 2017;179:204-22. [PMID: 27591027 DOI: 10.1016/j.trsl.2016.08.002] [Cited by in Crossref: 238] [Cited by in F6Publishing: 202] [Article Influence: 39.7] [Reference Citation Analysis]
167 Mehta O, Ghosh TS, Kothidar A, Gowtham MR, Mitra R, Kshetrapal P, Wadhwa N, Thiruvengadam R, Nair GB, Bhatnagar S, Das B; GARBH-Ini study group. Vaginal Microbiome of Pregnant Indian Women: Insights into the Genome of Dominant Lactobacillus Species. Microb Ecol 2020;80:487-99. [PMID: 32206831 DOI: 10.1007/s00248-020-01501-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
168 Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35:249-255. [PMID: 24302613 DOI: 10.1093/carcin/bgt392] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 14.7] [Reference Citation Analysis]
169 Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ, Ingber DE. Microfluidic Organ-on-a-Chip Models of Human Intestine. Cell Mol Gastroenterol Hepatol. 2018;5:659-668. [PMID: 29713674 DOI: 10.1016/j.jcmgh.2017.12.010] [Cited by in Crossref: 218] [Cited by in F6Publishing: 189] [Article Influence: 54.5] [Reference Citation Analysis]
170 Clavel T, Horz HP, Segata N, Vehreschild M. Next steps after 15 stimulating years of human gut microbiome research. Microb Biotechnol 2022;15:164-75. [PMID: 34818454 DOI: 10.1111/1751-7915.13970] [Reference Citation Analysis]
171 Fu ZD, Cui JY. Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. Curr Pharmacol Rep 2017;3:101-13. [PMID: 28983453 DOI: 10.1007/s40495-017-0087-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
172 Sharpton SR, Schnabl B, Knight R, Loomba R. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. Cell Metab 2021;33:21-32. [PMID: 33296678 DOI: 10.1016/j.cmet.2020.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
173 ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 2014;18:402-14. [PMID: 24785449 DOI: 10.1089/omi.2014.0018] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
174 Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 2019;570:462-7. [PMID: 31158845 DOI: 10.1038/s41586-019-1291-3] [Cited by in Crossref: 242] [Cited by in F6Publishing: 220] [Article Influence: 80.7] [Reference Citation Analysis]
175 Koppel N, Balskus EP. Exploring and Understanding the Biochemical Diversity of the Human Microbiota. Cell Chem Biol 2016;23:18-30. [PMID: 26933733 DOI: 10.1016/j.chembiol.2015.12.008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 13.2] [Reference Citation Analysis]
176 Alivisatos AP, Blaser MJ, Brodie EL, Chun M, Dangl JL, Donohue TJ, Dorrestein PC, Gilbert JA, Green JL, Jansson JK, Knight R, Maxon ME, McFall-Ngai MJ, Miller JF, Pollard KS, Ruby EG, Taha SA; Unified Microbiome Initiative Consortium. MICROBIOME. A unified initiative to harness Earth's microbiomes. Science 2015;350:507-8. [PMID: 26511287 DOI: 10.1126/science.aac8480] [Cited by in Crossref: 157] [Cited by in F6Publishing: 125] [Article Influence: 22.4] [Reference Citation Analysis]
177 Deutschman CS, Hellman J, Roca RF, De Backer D, Coopersmith CM; Research Committee of the Surviving Sepsis Campaign. The surviving sepsis campaign: basic/translational science research priorities. Intensive Care Med Exp 2020;8:31. [PMID: 32676795 DOI: 10.1186/s40635-020-00312-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
178 Joice R, Yasuda K, Shafquat A, Morgan XC, Huttenhower C. Determining microbial products and identifying molecular targets in the human microbiome. Cell Metab 2014;20:731-41. [PMID: 25440055 DOI: 10.1016/j.cmet.2014.10.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
179 Shafquat A, Joice R, Simmons SL, Huttenhower C. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol 2014;22:261-6. [PMID: 24618403 DOI: 10.1016/j.tim.2014.01.011] [Cited by in Crossref: 124] [Cited by in F6Publishing: 93] [Article Influence: 15.5] [Reference Citation Analysis]
180 Mesnage R, Teixeira M, Mandrioli D, Falcioni L, Ducarmon QR, Zwittink RD, Mazzacuva F, Caldwell A, Halket J, Amiel C, Panoff JM, Belpoggi F, Antoniou MN. Use of Shotgun Metagenomics and Metabolomics to Evaluate the Impact of Glyphosate or Roundup MON 52276 on the Gut Microbiota and Serum Metabolome of Sprague-Dawley Rats. Environ Health Perspect 2021;129:17005. [PMID: 33502259 DOI: 10.1289/EHP6990] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 24.0] [Reference Citation Analysis]
181 Payami H. The emerging science of precision medicine and pharmacogenomics for Parkinson's disease. Mov Disord 2017;32:1139-46. [PMID: 28686320 DOI: 10.1002/mds.27099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
182 Mythen SM, Devendran S, Méndez-García C, Cann I, Ridlon JM. Targeted Synthesis and Characterization of a Gene Cluster Encoding NAD(P)H-Dependent 3α-, 3β-, and 12α-Hydroxysteroid Dehydrogenases from Eggerthella CAG:298, a Gut Metagenomic Sequence. Appl Environ Microbiol 2018;84:e02475-17. [PMID: 29330189 DOI: 10.1128/AEM.02475-17] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
183 Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14:273-287. [PMID: 26972811 DOI: 10.1038/nrmicro.2016.17] [Cited by in Crossref: 341] [Cited by in F6Publishing: 298] [Article Influence: 56.8] [Reference Citation Analysis]
184 Lee K, Kim N, Shim JO, Kim GH. Gut Bacterial Dysbiosis in Children with Intractable Epilepsy. J Clin Med 2020;10:E5. [PMID: 33375063 DOI: 10.3390/jcm10010005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
185 Huttenhower C, Knight R, Brown CT, Caporaso JG, Clemente JC, Gevers D, Franzosa EA, Kelley ST, Knights D, Ley RE, Mahurkar A, Ravel J, White O; Scientists for Advancement of Microbiome Research. Advancing the microbiome research community. Cell 2014;159:227-30. [PMID: 25303518 DOI: 10.1016/j.cell.2014.09.022] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
186 Whidbey C, Sadler NC, Nair RN, Volk RF, Deleon AJ, Bramer LM, Fansler SJ, Hansen JR, Shukla AK, Jansson JK, Thrall BD, Wright AT. A Probe-Enabled Approach for the Selective Isolation and Characterization of Functionally Active Subpopulations in the Gut Microbiome. J Am Chem Soc 2019;141:42-7. [DOI: 10.1021/jacs.8b09668] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
187 Moore BD, Wiggins NL, Marsh KJ, Dearing MD, Foley WJ. Translating physiological signals to changes in feeding behaviour in mammals and the future effects of global climate change. Anim Prod Sci 2015;55:272. [DOI: 10.1071/an14487] [Cited by in Crossref: 19] [Article Influence: 2.7] [Reference Citation Analysis]
188 Rajakovich LJ, Balskus EP. Metabolic functions of the human gut microbiota: the role of metalloenzymes. Nat Prod Rep 2019;36:593-625. [PMID: 30452039 DOI: 10.1039/c8np00074c] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 9.7] [Reference Citation Analysis]
189 Yu AM, Ingelman-Sundberg M, Cherrington NJ, Aleksunes LM, Zanger UM, Xie W, Jeong H, Morgan ET, Turnbaugh PJ, Klaassen CD, Bhatt AP, Redinbo MR, Hao P, Waxman DJ, Wang L, Zhong XB. Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO). Acta Pharm Sin B 2017;7:241-8. [PMID: 28388695 DOI: 10.1016/j.apsb.2016.12.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
190 Litman T. Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases. APMIS 2019;127:386-424. [PMID: 31124204 DOI: 10.1111/apm.12934] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
191 White J, Reid G, Joly Y. A suggestion for evolution of Canada’s health regulatory system. FACETS 2018;3:45-60. [DOI: 10.1139/facets-2017-0049] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
192 Bartolomaeus H, Markó L, Wilck N, Luft FC, Forslund SK, Muller DN. Precarious Symbiosis Between Host and Microbiome in Cardiovascular Health. Hypertension 2019;73:926-35. [PMID: 30905198 DOI: 10.1161/HYPERTENSIONAHA.119.11786] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
193 Harris SC, Devendran S, Méndez-García C, Mythen SM, Wright CL, Fields CJ, Hernandez AG, Cann I, Hylemon PB, Ridlon JM. Bile acid oxidation by Eggerthella lenta strains C592 and DSM 2243T. Gut Microbes 2018;9:523-39. [PMID: 29617190 DOI: 10.1080/19490976.2018.1458180] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
194 Matuskova Z, Anzenbacherova E, Vecera R, Tlaskalova-Hogenova H, Kolar M, Anzenbacher P. Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. PLoS One 2014;9:e87150. [PMID: 24505278 DOI: 10.1371/journal.pone.0087150] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
195 Guthrie L, Wolfson S, Kelly L. The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs. Elife 2019;8:e42866. [PMID: 31184303 DOI: 10.7554/eLife.42866] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
196 Zimmermann M, Patil KR, Typas A, Maier L. Towards a mechanistic understanding of reciprocal drug-microbiome interactions. Mol Syst Biol 2021;17:e10116. [PMID: 33734582 DOI: 10.15252/msb.202010116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
197 Fang B, Li JW, Zhang M, Ren FZ, Pang GF. Chronic chlorpyrifos exposure elicits diet-specific effects on metabolism and the gut microbiome in rats. Food and Chemical Toxicology 2018;111:144-52. [DOI: 10.1016/j.fct.2017.11.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
198 Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, Gasbarrini A, Tortora G. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nat Rev Gastroenterol Hepatol 2020;17:635-48. [DOI: 10.1038/s41575-020-0327-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
199 Kashyap PC, Quigley EM. Therapeutic implications of the gastrointestinal microbiome. Current Opinion in Pharmacology 2018;38:90-6. [DOI: 10.1016/j.coph.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
200 Sun YZ, Zhang DH, Cai SB, Ming Z, Li JQ, Chen X. MDAD: A Special Resource for Microbe-Drug Associations. Front Cell Infect Microbiol 2018;8:424. [PMID: 30581775 DOI: 10.3389/fcimb.2018.00424] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
201 Westblade LF, van Belkum A, Grundhoff A, Weinstock GM, Pamer EG, Pallen MJ, Dunne WM Jr. Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology. J Clin Microbiol 2016;54:1686-93. [PMID: 26912755 DOI: 10.1128/JCM.02664-15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
202 Tralau T, Sowada J, Luch A. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology? Expert Opin Drug Metab Toxicol 2015;11:411-25. [PMID: 25476418 DOI: 10.1517/17425255.2015.990437] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
203 Chavira A, Belda-ferre P, Kosciolek T, Ali F, Dorrestein PC, Knight R. The Microbiome and Its Potential for Pharmacology. In: Barrett JE, Page CP, Michel MC, editors. Concepts and Principles of Pharmacology. Cham: Springer International Publishing; 2019. pp. 301-26. [DOI: 10.1007/164_2019_317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
204 Katsi V, Didagelos M, Skevofilax S, Armenis I, Kartalis A, Vlachopoulos C, Karvounis H, Tousoulis D. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons. Curr Hypertens Rev 2019;15:40-6. [PMID: 29895255 DOI: 10.2174/1573402114666180613080439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
205 Beresford-Jones BS, Forster SC, Stares MD, Notley G, Viciani E, Browne HP, Boehmler DJ, Soderholm AT, Kumar N, Vervier K, Cross JR, Almeida A, Lawley TD, Pedicord VA. The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping. Cell Host Microbe 2021:S1931-3128(21)00568-0. [PMID: 34971560 DOI: 10.1016/j.chom.2021.12.003] [Reference Citation Analysis]
206 Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science 2017;356:eaag2770. [PMID: 28642381 DOI: 10.1126/science.aag2770] [Cited by in Crossref: 325] [Cited by in F6Publishing: 302] [Article Influence: 81.3] [Reference Citation Analysis]
207 Tuteja S, Ferguson JF. Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med 2019;12:421-9. [PMID: 31462078 DOI: 10.1161/CIRCGEN.119.002314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
208 De Filippis F, Pasolli E, Tett A, Tarallo S, Naccarati A, De Angelis M, Neviani E, Cocolin L, Gobbetti M, Segata N, Ercolini D. Distinct Genetic and Functional Traits of Human Intestinal Prevotella copri Strains Are Associated with Different Habitual Diets. Cell Host & Microbe 2019;25:444-453.e3. [DOI: 10.1016/j.chom.2019.01.004] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 37.3] [Reference Citation Analysis]
209 Baptista LC, Sun Y, Carter CS, Buford TW. Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty. Front Nutr 2020;7:17. [PMID: 32219095 DOI: 10.3389/fnut.2020.00017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
210 Gilbert JA, Quinn RA, Debelius J, Xu ZZ, Morton J, Garg N, Jansson JK, Dorrestein PC, Knight R. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535:94-103. [PMID: 27383984 DOI: 10.1038/nature18850] [Cited by in Crossref: 388] [Cited by in F6Publishing: 315] [Article Influence: 64.7] [Reference Citation Analysis]
211 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Reference Citation Analysis]
212 Mallick H, Ma S, Franzosa EA, Vatanen T, Morgan XC, Huttenhower C. Experimental design and quantitative analysis of microbial community multiomics. Genome Biol 2017;18:228. [PMID: 29187204 DOI: 10.1186/s13059-017-1359-z] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 15.8] [Reference Citation Analysis]
213 Huang W, Zhang W. Pharmacomicrobiomics. In: Cai W, Liu Z, Miao L, Xiang X, editors. Pharmacogenomics in Precision Medicine. Singapore: Springer; 2020. pp. 181-99. [DOI: 10.1007/978-981-15-3895-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Bourlioux P. Actualité du microbiote intestinal. Annales Pharmaceutiques Françaises 2014;72:15-21. [DOI: 10.1016/j.pharma.2013.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
215 Geva‐zatorsky N, Elinav E, Pettersson S. When Cultures Meet: The Landscape of “Social” Interactions between the Host and Its Indigenous Microbes. BioEssays 2019;41:1900002. [DOI: 10.1002/bies.201900002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
217 Wu N, Mah C, Koentgen S, Zhang L, Grimm MC, El-Omar E, Hold GL. Inflammatory bowel disease and the gut microbiota. Proc Nutr Soc 2021;:1-11. [PMID: 34165053 DOI: 10.1017/S002966512100197X] [Reference Citation Analysis]
218 Plichta DR, Somani J, Pichaud M, Wallace ZS, Fernandes AD, Perugino CA, Lähdesmäki H, Stone JH, Vlamakis H, Chung DC, Khanna D, Pillai S, Xavier RJ. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis. Genome Med 2021;13:35. [PMID: 33648559 DOI: 10.1186/s13073-021-00853-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
219 McCoubrey LE, Thomaidou S, Elbadawi M, Gaisford S, Orlu M, Basit AW. Machine Learning Predicts Drug Metabolism and Bioaccumulation by Intestinal Microbiota. Pharmaceutics 2021;13:2001. [PMID: 34959282 DOI: 10.3390/pharmaceutics13122001] [Reference Citation Analysis]
220 Cho GS, Ritzmann F, Eckstein M, Huch M, Briviba K, Behsnilian D, Neve H, Franz CM. Quantification of Slackia and Eggerthella spp. in Human Feces and Adhesion of Representatives Strains to Caco-2 Cells. Front Microbiol 2016;7:658. [PMID: 27242689 DOI: 10.3389/fmicb.2016.00658] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
221 Abu-Ali GS, Mehta RS, Lloyd-Price J, Mallick H, Branck T, Ivey KL, Drew DA, DuLong C, Rimm E, Izard J, Chan AT, Huttenhower C. Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nat Microbiol 2018;3:356-66. [PMID: 29335555 DOI: 10.1038/s41564-017-0084-4] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 22.3] [Reference Citation Analysis]
222 Schmidt TSB, Raes J, Bork P. The Human Gut Microbiome: From Association to Modulation. Cell 2018;172:1198-215. [PMID: 29522742 DOI: 10.1016/j.cell.2018.02.044] [Cited by in Crossref: 285] [Cited by in F6Publishing: 238] [Article Influence: 95.0] [Reference Citation Analysis]
223 Yan A, Culp E, Perry J, Lau JT, MacNeil LT, Surette MG, Wright GD. Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome. ACS Infect Dis 2018;4:68-76. [PMID: 29160065 DOI: 10.1021/acsinfecdis.7b00166] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
224 Pevsner-Fischer M, Blacher E, Tatirovsky E, Ben-Dov IZ, Elinav E. The gut microbiome and hypertension. Curr Opin Nephrol Hypertens 2017;26:1-8. [PMID: 27798455 DOI: 10.1097/MNH.0000000000000293] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
225 Su J, Li D, Chen Q, Li M, Su L, Luo T, Liang D, Lai G, Shuai O, Jiao C, Wu Q, Xie Y, Zhou X. Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping. Front Microbiol 2018;9:3099. [PMID: 30619178 DOI: 10.3389/fmicb.2018.03099] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
226 Park GS, Park MH, Shin W, Zhao C, Sheikh S, Oh SJ, Kim HJ. Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro. Stem Cell Rev Rep 2017;13:321-34. [PMID: 28488235 DOI: 10.1007/s12015-017-9739-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
227 Gong X, Liu Y, Liu X, Li AQ, Guo KD, Zhou D, Hong Z. Analysis of gut microbiota in patients with epilepsy treated with valproate: Results from a three months observational prospective cohort study. Microb Pathog 2021;162:105340. [PMID: 34883229 DOI: 10.1016/j.micpath.2021.105340] [Reference Citation Analysis]
228 Mamic P, Chaikijurajai T, Tang WHW. Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review. J Mol Cell Cardiol 2021;152:105-17. [PMID: 33307092 DOI: 10.1016/j.yjmcc.2020.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
229 García-Bayona L, Comstock LE. Bacterial antagonism in host-associated microbial communities. Science 2018;361:eaat2456. [PMID: 30237322 DOI: 10.1126/science.aat2456] [Cited by in Crossref: 109] [Cited by in F6Publishing: 83] [Article Influence: 27.3] [Reference Citation Analysis]
230 Nycz J, Zajdel A. Mikrobiota jelitowa a leki. Interakcje wpływające na skuteczność i bezpieczeństwo farmakoterapii. Postępy Higieny i Medycyny Doświadczalnej 2021;75:762-72. [DOI: 10.2478/ahem-2021-0009] [Reference Citation Analysis]
231 Su J, Su L, Li D, Shuai O, Zhang Y, Liang H, Jiao C, Xu Z, Lai Y, Xie Y. Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling. Front Immunol 2018;9:1765. [PMID: 30108589 DOI: 10.3389/fimmu.2018.01765] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
232 Kim JS, Sze C, Barbar T, Lee JR. New insights into the microbiome in kidney transplantation. Curr Opin Organ Transplant 2021;26:582-6. [PMID: 34534173 DOI: 10.1097/MOT.0000000000000921] [Reference Citation Analysis]
233 Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol 2019;16:137-54. [PMID: 30410105 DOI: 10.1038/s41569-018-0108-7] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 73.0] [Reference Citation Analysis]
234 Chae S, Kim DJ, Cho JY. Complex influences of gut microbiome metabolism on various drug responses. Transl Clin Pharmacol 2020;28:7-16. [PMID: 32274377 DOI: 10.12793/tcp.2020.28.e3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
235 Zhang J, Zhang J, Wang R, Jia Z. Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes. Curr Drug Metab 2019;20:155-65. [PMID: 30338735 DOI: 10.2174/1389200219666181019145159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
236 Nuzzo A, Brown JR. The Microbiome Factor in Drug Discovery and Development. Chem Res Toxicol 2020;33:119-24. [DOI: 10.1021/acs.chemrestox.9b00333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Savage N. The complex relationship between drugs and the microbiome. Nature 2020;577:S10-1. [PMID: 31996826 DOI: 10.1038/d41586-020-00196-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
238 Zimmermann-Kogadeeva M, Zimmermann M, Goodman AL. Insights from pharmacokinetic models of host-microbiome drug metabolism. Gut Microbes 2020;11:587-96. [PMID: 31564204 DOI: 10.1080/19490976.2019.1667724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
239 Camelo-Castillo A, Rivera-Caravaca JM, Orenes-Piñero E, Ramírez-Macías I, Roldán V, Lip GYH, Marín F. Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. J Clin Med 2021;10:715. [PMID: 33670220 DOI: 10.3390/jcm10040715] [Reference Citation Analysis]
240 Li L, Zhang X, Ning Z, Mayne J, Moore JI, Butcher J, Chiang CK, Mack D, Stintzi A, Figeys D. Evaluating in Vitro Culture Medium of Gut Microbiome with Orthogonal Experimental Design and a Metaproteomics Approach. J Proteome Res 2018;17:154-63. [PMID: 29130306 DOI: 10.1021/acs.jproteome.7b00461] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
241 Dempsey JL, Wang D, Siginir G, Fei Q, Raftery D, Gu H, Yue Cui J. Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis. Toxicol Sci 2019;168:40-60. [PMID: 30407581 DOI: 10.1093/toxsci/kfy271] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
242 Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature 2019;569:641-8. [PMID: 31142853 DOI: 10.1038/s41586-019-1238-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Mishra SP, Jain S, Taraphder S, Yadav H. New Horizons in Microbiota and Metabolic Health Research. J Clin Endocrinol Metab 2021;106:e1052-9. [PMID: 33128374 DOI: 10.1210/clinem/dgaa769] [Reference Citation Analysis]
244 Jumpertz von Schwartzenberg R, Turnbaugh PJ. Siri, What Should I Eat? Cell 2015;163:1051-2. [PMID: 26590412 DOI: 10.1016/j.cell.2015.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
245 Kinross J, Li JV, Muirhead LJ, Nicholson J. Nutritional modulation of the metabonome: applications of metabolic phenotyping in translational nutritional research. Curr Opin Gastroenterol 2014;30:196-207. [PMID: 24468802 DOI: 10.1097/MOG.0000000000000036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
246 Javdan B, Lopez JG, Chankhamjon P, Lee YJ, Hull R, Wu Q, Wang X, Chatterjee S, Donia MS. Personalized Mapping of Drug Metabolism by the Human Gut Microbiome. Cell 2020;181:1661-1679.e22. [PMID: 32526207 DOI: 10.1016/j.cell.2020.05.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 21.5] [Reference Citation Analysis]
247 Smith VH, Rubinstein RJ, Park S, Kelly L, Klepac-Ceraj V. Microbiology and ecology are vitally important to premedical curricula. Evol Med Public Health 2015;2015:179-92. [PMID: 26198190 DOI: 10.1093/emph/eov014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
248 Doestzada M, Vila AV, Zhernakova A, Koonen DPY, Weersma RK, Touw DJ, Kuipers F, Wijmenga C, Fu J. Pharmacomicrobiomics: a novel route towards personalized medicine? Protein Cell 2018;9:432-45. [PMID: 29705929 DOI: 10.1007/s13238-018-0547-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
249 Kumar R, Sood U, Kaur J, Anand S, Gupta V, Patil KS, Lal R. The rising dominance of microbiology: what to expect in the next 15 years? Microb Biotechnol 2021. [PMID: 34713975 DOI: 10.1111/1751-7915.13953] [Reference Citation Analysis]
250 Wang J, Jia H. Metagenome-wide association studies: fine-mining the microbiome. Nat Rev Microbiol 2016;14:508-22. [PMID: 27396567 DOI: 10.1038/nrmicro.2016.83] [Cited by in Crossref: 215] [Cited by in F6Publishing: 172] [Article Influence: 35.8] [Reference Citation Analysis]
251 Mussap M, Loddo C, Fanni C, Fanos V. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics. Expert Rev Clin Pharmacol 2020;13:115-34. [PMID: 31958027 DOI: 10.1080/17512433.2020.1713750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
252 Lu L, Wu Y, Zuo L, Luo X, Large PJ. Intestinal microbiome and digoxin inactivation: meal plan for digoxin users? World J Microbiol Biotechnol 2014;30:791-9. [PMID: 24105082 DOI: 10.1007/s11274-013-1507-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
253 Velmurugan G. Gut microbiota in toxicological risk assessment of drugs and chemicals: The need of hour. Gut Microbes 2018;9:465-8. [PMID: 29509057 DOI: 10.1080/19490976.2018.1445955] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
254 Dey P. The pharmaco-toxicological conundrum of oleander: Potential role of gut microbiome. Biomedicine & Pharmacotherapy 2020;129:110422. [DOI: 10.1016/j.biopha.2020.110422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
255 Dearing MD, Kohl KD. Beyond Fermentation: Other Important Services Provided to Endothermic Herbivores by their Gut Microbiota. Integr Comp Biol 2017;57:723-31. [PMID: 28662572 DOI: 10.1093/icb/icx020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
256 Aguiar-Pulido V, Huang W, Suarez-Ulloa V, Cickovski T, Mathee K, Narasimhan G. Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis. Evol Bioinform Online 2016;12:5-16. [PMID: 27199545 DOI: 10.4137/EBO.S36436] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 10.2] [Reference Citation Analysis]
257 Ryu G, Kim H, Koh A. Approaching precision medicine by tailoring the microbiota. Mamm Genome 2021;32:206-22. [PMID: 33646347 DOI: 10.1007/s00335-021-09859-3] [Reference Citation Analysis]
258 Naik A, Misra SK. Modern Sensing Approaches for Predicting Toxicological Responses of Food- and Drug-Based Bioactives on Microbiomes of Gut Origin. J Agric Food Chem 2021;69:6396-413. [PMID: 34081444 DOI: 10.1021/acs.jafc.1c02736] [Reference Citation Analysis]
259 Leone VA, Cham CM, Chang EB. Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases? Curr Opin Immunol 2014;31:16-23. [PMID: 25214301 DOI: 10.1016/j.coi.2014.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
260 Sayers E, MacGregor A, Carding SR. Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis. AIMS Microbiol 2018;4:642-54. [PMID: 31294239 DOI: 10.3934/microbiol.2018.4.642] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
261 Zhao Y, Wang Z. Gut microbiome and cardiovascular disease. Curr Opin Cardiol 2020;35:207-18. [PMID: 32068612 DOI: 10.1097/HCO.0000000000000720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
262 Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
263 Sharma AK, Jaiswal SK, Chaudhary N, Sharma VK. A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Sci Rep 2017;7:9751. [PMID: 28852076 DOI: 10.1038/s41598-017-10203-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
264 Bartolomaeus H, McParland V, Wilck N. [Gut-heart axis : How gut bacteria influence cardiovascular diseases]. Herz 2020;45:134-41. [PMID: 32077981 DOI: 10.1007/s00059-020-04897-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Doherty MK, Ding T, Koumpouras C, Telesco SE, Monast C, Das A, Brodmerkel C, Schloss PD. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients. mBio 2018;9:e02120-17. [PMID: 29535202 DOI: 10.1128/mBio.02120-17] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 12.8] [Reference Citation Analysis]
266 Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: A microbiome-gut-brain axis disorder? World J Gastroenterol 2014; 20(39): 14105-14125 [PMID: 25339800 DOI: 10.3748/wjg.v20.i39.14105] [Cited by in CrossRef: 178] [Cited by in F6Publishing: 146] [Article Influence: 22.3] [Reference Citation Analysis]
267 Deng L, Huang Y, Liu X, Liu H. Graph2MDA: a multi-modal variational graph embedding model for predicting microbe-drug associations. Bioinformatics 2021:btab792. [PMID: 34864873 DOI: 10.1093/bioinformatics/btab792] [Reference Citation Analysis]
268 Bik EM, Ugalde JA, Cousins J, Goddard AD, Richman J, Apte ZS. Microbial biotransformations in the human distal gut. Br J Pharmacol 2018;175:4404-14. [PMID: 29116650 DOI: 10.1111/bph.14085] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
269 McCoubrey LE, Gaisford S, Orlu M, Basit AW. Predicting drug-microbiome interactions with machine learning. Biotechnol Adv 2021;:107797. [PMID: 34260950 DOI: 10.1016/j.biotechadv.2021.107797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
270 Wlodarska M, Johnston JC, Gardy JL, Tang P. A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics. Clin Microbiol Rev 2015;28:523-39. [PMID: 25810419 DOI: 10.1128/CMR.00124-14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
271 Schirmer M, Denson L, Vlamakis H, Franzosa EA, Thomas S, Gotman NM, Rufo P, Baker SS, Sauer C, Markowitz J, Pfefferkorn M, Oliva-Hemker M, Rosh J, Otley A, Boyle B, Mack D, Baldassano R, Keljo D, LeLeiko N, Heyman M, Griffiths A, Patel AS, Noe J, Kugathasan S, Walters T, Huttenhower C, Hyams J, Xavier RJ. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. Cell Host Microbe 2018; 24: 600-610. e4. [PMID: 30308161 DOI: 10.1016/j.chom.2018.09.009] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 18.5] [Reference Citation Analysis]
272 Clark LC, Hodgkin J. Commensals, probiotics and pathogens in the Caenorhabditis elegans model. Cell Microbiol 2014;16:27-38. [PMID: 24168639 DOI: 10.1111/cmi.12234] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
273 Yip LY, Chan EC. Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome. Drug Metab Dispos 2015;43:1619-31. [PMID: 25979259 DOI: 10.1124/dmd.115.063750] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
274 Bhushan B, Singh BP, Saini K, Kumari M, Tomar SK, Mishra V. Role of microbes, metabolites and effector compounds in host–microbiota interaction: a pharmacological outlook. Environ Chem Lett 2019;17:1801-20. [DOI: 10.1007/s10311-019-00914-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
275 Seyed Hameed AS, Rawat PS, Meng X, Liu W. Biotransformation of dietary phytoestrogens by gut microbes: A review on bidirectional interaction between phytoestrogen metabolism and gut microbiota. Biotechnol Adv 2020;43:107576. [PMID: 32531317 DOI: 10.1016/j.biotechadv.2020.107576] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
276 Staley C, Kaiser T, Khoruts A. Clinician Guide to Microbiome Testing. Dig Dis Sci 2018;63:3167-77. [PMID: 30267172 DOI: 10.1007/s10620-018-5299-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
277 Chen J, Mao Y, Xing C, Hu R, Xu Z, Cao H, Luo J. Traditional Chinese Medicine Prescriptions Decrease Diarrhea Rate by Relieving Colonic Inflammation and Ameliorating Caecum Microbiota in Piglets. Evid Based Complement Alternat Med 2020;2020:3647525. [PMID: 32351595 DOI: 10.1155/2020/3647525] [Reference Citation Analysis]
278 Viswanathan V. The meddling microbes midst our medicines. Gut Microbes 2013;4:359-60. [PMID: 23969979 DOI: 10.4161/gmic.26250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
279 Sharma A, Das P, Buschmann M, Gilbert JA. The Future of Microbiome-Based Therapeutics in Clinical Applications. Clin Pharmacol Ther 2020;107:123-8. [PMID: 31617205 DOI: 10.1002/cpt.1677] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
280 Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature. 2019;569:641-648. [PMID: 31142853 DOI: 10.1038/s41586-019-1238-8] [Cited by in Crossref: 276] [Cited by in F6Publishing: 193] [Article Influence: 92.0] [Reference Citation Analysis]
281 Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L, Gao X, Zhu B, Lei XG, Gu Z, Cui W, Xu X, Li Z, Zhu B, Li Y, Chen S, Guo H, Zhang H, Sun J, Zhang M, Hui Y, Zhang X, Liu X, Sun B, Wang L, Qiu Q, Zhang Y, Li X, Liu W, Xue R, Wu H, Shao D, Li J, Zhou Y, Li S, Yang R, Pedersen OB, Yu Z, Ehrlich SD, Ren F. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 2020;69:2131-42. [PMID: 32241904 DOI: 10.1136/gutjnl-2019-319766] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
282 Guthrie L, Gupta S, Daily J, Kelly L. Human microbiome signatures of differential colorectal cancer drug metabolism. NPJ Biofilms Microbiomes. 2017;3:27. [PMID: 29104759 DOI: 10.1038/s41522-017-0034-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
283 Carrow HC, Batachari LE, Chu H. Strain diversity in the microbiome: Lessons from Bacteroides fragilis. PLoS Pathog 2020;16:e1009056. [PMID: 33301530 DOI: 10.1371/journal.ppat.1009056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
284 Karl JP, Hatch AM, Arcidiacono SM, Pearce SC, Pantoja-Feliciano IG, Doherty LA, Soares JW. Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front Microbiol 2018;9:2013. [PMID: 30258412 DOI: 10.3389/fmicb.2018.02013] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 33.0] [Reference Citation Analysis]
285 Quinn RA, Navas-Molina JA, Hyde ER, Song SJ, Vázquez-Baeza Y, Humphrey G, Gaffney J, Minich JJ, Melnik AV, Herschend J, DeReus J, Durant A, Dutton RJ, Khosroheidari M, Green C, da Silva R, Dorrestein PC, Knight R. From Sample to Multi-Omics Conclusions in under 48 Hours. mSystems 2016;1:e00038-16. [PMID: 27822524 DOI: 10.1128/mSystems.00038-16] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
286 Maier L, Typas A. Systematically investigating the impact of medication on the gut microbiome. Curr Opin Microbiol 2017;39:128-35. [PMID: 29169088 DOI: 10.1016/j.mib.2017.11.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
287 Shaffer M, Armstrong AJS, Phelan VV, Reisdorph N, Lozupone CA. Microbiome and metabolome data integration provides insight into health and disease. Transl Res 2017;189:51-64. [PMID: 28764956 DOI: 10.1016/j.trsl.2017.07.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
288 Ravel J, Blaser MJ, Braun J, Brown E, Bushman FD, Chang EB, Davies J, Dewey KG, Dinan T, Dominguez-bello M, Erdman SE, Finlay BB, Garrett WS, Huffnagle GB, Huttenhower C, Jansson J, Jeffery IB, Jobin C, Khoruts A, Kong HH, Lampe JW, Ley RE, Littman DR, Mazmanian SK, Mills DA, Neish AS, Petrof E, Relman DA, Rhodes R, Turnbaugh PJ, Young VB, Knight R, White O. Human microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013. Microbiome 2014;2. [DOI: 10.1186/2049-2618-2-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
289 Degraeve AL, Moudio S, Haufroid V, Chaib Eddour D, Mourad M, Bindels LB, Elens L. Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives. Expert Opin Drug Metab Toxicol 2020;16:769-82. [PMID: 32721175 DOI: 10.1080/17425255.2020.1803277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
290 Cong J, Zhu J, Zhang C, Li T, Liu K, Liu D, Zhou N, Jiang M, Hou H, Zhang X. Chemotherapy Alters the Phylogenetic Molecular Ecological Networks of Intestinal Microbial Communities. Front Microbiol 2019;10:1008. [PMID: 31134034 DOI: 10.3389/fmicb.2019.01008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
291 Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 2015;33:227-56. [PMID: 25581310 DOI: 10.1146/annurev-immunol-032713-120238] [Cited by in Crossref: 152] [Cited by in F6Publishing: 136] [Article Influence: 21.7] [Reference Citation Analysis]
292 Sharma A, Gilbert JA. Microbial exposure and human health. Current Opinion in Microbiology 2018;44:79-87. [DOI: 10.1016/j.mib.2018.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
293 Cong J, Zhang Y, Xue Y, Zhang C, Xu M, Liu D, Zhang R, Zhu H. A Pilot Study: Changes of Intestinal Microbiota of Patients With Non-small Cell Lung Cancer in Response to Osimertinib Therapy. Front Microbiol 2020;11:583525. [PMID: 33240237 DOI: 10.3389/fmicb.2020.583525] [Reference Citation Analysis]
294 Nayak RR, Turnbaugh PJ. Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med. 2016;14:72. [PMID: 27146150 DOI: 10.1186/s12916-016-0622-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
295 Beebe K, Sampey B, Watkins SM, Milburn M, Eckhart AD. Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. Clin Transl Sci 2014;7:74-81. [PMID: 24422665 DOI: 10.1111/cts.12131] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
296 Alegre ML, Mannon RB, Mannon PJ. The microbiota, the immune system and the allograft. Am J Transplant 2014;14:1236-48. [PMID: 24840316 DOI: 10.1111/ajt.12760] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
297 Curini L, Amedei A. Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance. Biomedicines 2021;9:1338. [PMID: 34680455 DOI: 10.3390/biomedicines9101338] [Reference Citation Analysis]
298 Klaassen CD, Cui JY. Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos 2015;43:1505-21. [PMID: 26261286 DOI: 10.1124/dmd.115.065698] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 14.7] [Reference Citation Analysis]
299 Mehmood K, Moin A, Hussain T, Rizvi SMD, Gowda DV, Shakil S, Kamal MA. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management? Folia Microbiol (Praha) 2021;66:897-916. [PMID: 34699042 DOI: 10.1007/s12223-021-00926-5] [Reference Citation Analysis]
300 Nakov R, Velikova T. Chemical Metabolism of Xenobiotics by Gut Microbiota. Curr Drug Metab 2020;21:260-9. [PMID: 32124693 DOI: 10.2174/1389200221666200303113830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
301 Blanco-Míguez A, Fdez-Riverola F, Sánchez B, Lourenço A. Resources and tools for the high-throughput, multi-omic study of intestinal microbiota. Brief Bioinform 2019;20:1032-56. [PMID: 29186315 DOI: 10.1093/bib/bbx156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
302 Amedei A, Morbidelli L. Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function. Molecules 2019;24:E3992. [PMID: 31694161 DOI: 10.3390/molecules24213992] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
303 Guthrie L, Kelly L. Bringing microbiome-drug interaction research into the clinic. EBioMedicine 2019;44:708-15. [PMID: 31151933 DOI: 10.1016/j.ebiom.2019.05.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
304 Zmora N, Zeevi D, Korem T, Segal E, Elinav E. Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease. Cell Host Microbe. 2016;19:12-20. [PMID: 26764593 DOI: 10.1016/j.chom.2015.12.016] [Cited by in Crossref: 136] [Cited by in F6Publishing: 113] [Article Influence: 22.7] [Reference Citation Analysis]
305 Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. Journal of Hepatology 2019;70:260-72. [DOI: 10.1016/j.jhep.2018.10.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 23.3] [Reference Citation Analysis]
306 Soto-Perez P, Bisanz JE, Berry JD, Lam KN, Bondy-Denomy J, Turnbaugh PJ. CRISPR-Cas System of a Prevalent Human Gut Bacterium Reveals Hyper-targeting against Phages in a Human Virome Catalog. Cell Host Microbe 2019;26:325-335.e5. [PMID: 31492655 DOI: 10.1016/j.chom.2019.08.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
307 Marques FZ, Mackay CR, Kaye DM. Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol 2018;15:20-32. [PMID: 28836619 DOI: 10.1038/nrcardio.2017.120] [Cited by in Crossref: 142] [Cited by in F6Publishing: 137] [Article Influence: 28.4] [Reference Citation Analysis]
308 Xu L, Li X, Zhang E, Liang H, Li W, Wang S, Song S, Ji A. The effect of leech extracts on endothelial cell coagulation-related factors and endothelial dysfuction-related molecules. Clinical and Experimental Hypertension 2019;41:220-30. [DOI: 10.1080/10641963.2018.1465076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
309 Lai PS, Christiani DC. Impact of occupational exposure on human microbiota. Curr Opin Allergy Clin Immunol 2019;19:86-91. [PMID: 30507717 DOI: 10.1097/ACI.0000000000000502] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
310 Tarasiuk A, Fichna J. Gut microbiota: what is its place in pharmacology? Expert Review of Clinical Pharmacology 2019;12:921-30. [DOI: 10.1080/17512433.2019.1670058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
311 Peisl BYL, Schymanski EL, Wilmes P. Dark matter in host-microbiome metabolomics: Tackling the unknowns-A review. Anal Chim Acta 2018;1037:13-27. [PMID: 30292286 DOI: 10.1016/j.aca.2017.12.034] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
312 Garud N. The Tempo and Mode of Adaptation in a Complex Natural Population: the Microbiome. mSystems 2021;6:e0077921. [PMID: 34427524 DOI: 10.1128/mSystems.00779-21] [Reference Citation Analysis]
313 Ha CWY, Devkota S. The new microbiology: cultivating the future of microbiome-directed medicine. Am J Physiol Gastrointest Liver Physiol 2020;319:G639-45. [PMID: 32996782 DOI: 10.1152/ajpgi.00093.2020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Thiele I, Clancy CM, Heinken A, Fleming RMT. Quantitative systems pharmacology and the personalized drug-microbiota-diet axis. Curr Opin Syst Biol 2017;4:43-52. [PMID: 32984662 DOI: 10.1016/j.coisb.2017.06.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
315 Muller E, Algavi YM, Borenstein E. A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations. Microbiome 2021;9:203. [PMID: 34641974 DOI: 10.1186/s40168-021-01149-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Yang K, Xu M, Zhu J. Evaluating the Impact of Four Major Nutrients on Gut Microbial Metabolism by a Targeted Metabolomics Approach. J Proteome Res 2020;19:1991-8. [PMID: 32275156 DOI: 10.1021/acs.jproteome.9b00806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
317 Clarke G, Sandhu KV, Griffin BT, Dinan TG, Cryan JF, Hyland NP, France CP. Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions. Pharmacol Rev 2019;71:198-224. [DOI: 10.1124/pr.118.015768] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 33.7] [Reference Citation Analysis]
318 Turnbaugh PJ. Making Millennial Medicine More Meta. mSystems 2018;3:e00154-17. [PMID: 29556544 DOI: 10.1128/mSystems.00154-17] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
319 Zhong J, Guo K, Liao Z, Hu S, Du Y, Ji X. Comparative analysis of the gut microbiota composition between two sea snakes, Hydrophis curtus, and Hydrophis cyanocinctus. Coral Reefs. [DOI: 10.1007/s00338-021-02200-z] [Reference Citation Analysis]
320 Ma TK, Chow KM, Choy AS, Kwan BC, Szeto CC, Li PK. Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients. Clin Kidney J 2014;7:507-12. [PMID: 25859365 DOI: 10.1093/ckj/sfu098] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
321 De Cesare A, Sala C, Castellani G, Astolfi A, Indio V, Giardini A, Manfreda G. Effect of Lactobacillus acidophilus D2/CSL (CECT 4529) supplementation in drinking water on chicken crop and caeca microbiome. PLoS One 2020;15:e0228338. [PMID: 31978143 DOI: 10.1371/journal.pone.0228338] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
322 Hannachi N, Camoin-Jau L. Drug Response Diversity: A Hidden Bacterium? J Pers Med 2021;11:345. [PMID: 33922920 DOI: 10.3390/jpm11050345] [Reference Citation Analysis]
323 Becattini S, Taur Y, Pamer EG. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med. 2016;22:458-478. [PMID: 27178527 DOI: 10.1016/j.molmed.2016.04.003] [Cited by in Crossref: 331] [Cited by in F6Publishing: 297] [Article Influence: 55.2] [Reference Citation Analysis]